Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 8/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.60 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | PGR | P06401 | 1/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.60 |
| ▸ | AR | P10275 | 1/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | DRD1 | P21728 | 1/20 | 0.60 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL895990 | 1.00 | ESR1 (0.60) | ESR1ALOX15SLC6A2TDP1LMNA | |
| SCHEMBL895763 | 1.00 | ESR1 (0.60) | ESR1ALOX15SLC6A2TDP1LMNA | |
| Hydrochloric Acid SCHEMBL2364486 | 0.98 | ESR1 (0.58) | ESR1ALOX15SLC6A2TDP1LMNA | |
| SCHEMBL23092069 | 0.87 | SLC6A4 (0.70) | ESR1ALOX15SLC6A2TDP1LMNA | |
| SCHEMBL12056794 | 0.82 | ESR1 (0.53) | ESR1ALOX15SLC6A2TDP1LMNA | |
| SCHEMBL18782791 | 0.81 | ESR1 (0.50) | ESR1ALOX15SLC6A2TDP1LMNA | |
| SCHEMBL3975453 | 0.79 | SLC2A1 (0.51) | ESR1ALOX15SLC6A2TDP1LMNA | |
| SCHEMBL3865060 | 0.78 | SLC6A4 (0.59) | ESR1ALOX15SLC6A2TDP1LMNA | |
| SCHEMBL8286101 | 0.78 | SLC6A4 (0.59) | ESR1ALOX15SLC6A2TDP1LMNA | |
| SCHEMBL3041323 | 0.78 | TAAR1 (0.48) | ESR1ALOX15SLC6A2TDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036599-A | Dibenzylbutane lignan LCA analogue, and preparation method and application thereof | 浙江中医药大学 | 2026-05-15 | — | — | CN | claimed |
| CN-116813497-B | Amide compound and preparation method, pharmaceutical composition and application thereof | 天津匠新致成科技有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-108249473-B | Preparation method and application of rod-shaped zinc oxide gas-sensitive material | 黑龙江大学 | 2020-06-23 | — | — | CN | claimed |
| US-9879293-B2 | Enzymatic transamination of cyclopamine analogs | INFINITY PHARMACEUTICALS, INC. (US) | 2018-01-30 | — | — | US | claimed |
| US-20160177354-A1 | ENZYMATIC TRANSAMINATION OF CYCLOPAMINE ANALOGS | SAFC, INC. | 2016-06-23 | — | — | US | claimed |
| EP-2462115-B1 | ENZYMATIC TRANSAMINATION OF CYCLOPAMINE ANALOGS | INFINITY PHARMACEUTICALS INC (US) | 2016-01-06 | — | — | EP | claimed |
| EP-2744908-A1 | ENZYMATIC SYNTHESIS OF OPTICALLY ACTIVE CHIRAL AMINES | Embio Limited (IN) | 2014-06-25 | — | — | EP | claimed |
| US-8703448-B2 | Enzymatic transamination of cyclopamine analogs | INFINITY PHARMACEUTICALS, INC. (US) | 2014-04-22 | — | — | US | claimed |
| US-20140099682-A1 | Enzymatic Synthesis of Optically Active Chiral Amines | EMBIO LIMITED (IN) | 2014-04-10 | — | — | US | claimed |
| WO-2013024453-A1 | ENZYMATIC SYNTHESIS OF OPTICALLY ACTIVE CHIRAL AMINES | EMBIO LIMITED (IN) | 2013-02-21 | — | — | WO | claimed |
| CN-102574791-A | Enzymatic transamination of cyclopamine analogs | INFINITY PHARMACEUTICALS INC | 2012-07-11 | — | — | CN | claimed |
| US-20120083607-A1 | Enzymatic Transamination of Cyclopamine Analogs | INFINITY PHARMACEUTICALS, INC. (US) | 2012-04-05 | — | — | US | claimed |
| CN-122036599-A | Dibenzylbutane lignan LCA analogue, and preparation method and application thereof | 浙江中医药大学 | 2026-05-15 | — | — | CN | disclosed |
| US-20260078417-A1 | TRANSAMINASE BIOCATALYSTS | CODEXIS, INC. (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260028600-A1 | TRANSAMINASE POLYPEPTIDES | CODEXIS INC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12448611-B2 | Transaminase polypeptides | CODEXIS, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| US-4950606-A | CONTACTING IN AN AQUEOUS MEDIUM IN THE PRESENCE OF AN AMINO ACCEPTOR WITH AN OMEGA-AMINO ACID TRANSAMINASE TO CONVERT ONE OF AMINES TO KETONE | CELGENE CORPORATION (US) | 1990-08-21 | — | — | US | disclosed |
| US-4895849-A | Aralkylaminopyrimidine compounds which are useful as for producing thereof and insecticides | UBE INDUSTRIES, LTD. (JP) | 1990-01-23 | — | — | US | disclosed |
| EP-0264217-A2 | Aralkylaminopyrimidine derivative, process for producing thereof and insecticide, acaricide and fungicide containing said derivative as active ingredient | UBE INDUSTRIES, LTD. (JP) | 1988-04-20 | — | — | EP | disclosed |
| EP-0255415-A2 | Use of phenylethanolamines for the preparation of medicaments acting on gastrointestinal troubles | ELF SANOFI (FR) | 1988-02-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120083607-A1 | Enzymatic Transamination of Cyclopamine Analogs | TKT, TALDO1, BCHE | ESR1 4827/4885ALOX15 2034/4885SLC6A2 3119/4885 |
| US-20260028600-A1 | TRANSAMINASE POLYPEPTIDES | GOT1, OAT, PEPD | ESR1 3431/4885ALOX15 4256/4885SLC6A2 528/4885 |
| US-20260078417-A1 | TRANSAMINASE BIOCATALYSTS | XDH, AGXT, PEPD | ESR1 3480/4885ALOX15 3792/4885SLC6A2 820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.